GT
HZNP
Glenmede Trust’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-388
| Closed | -$30K | – | 2566 |
|
|
2020
Q3 | $30K | Sell |
388
-652,194
| -100% | -$50.4M | ﹤0.01% | 1463 |
|
|
2020
Q2 | $36.3M | Sell |
652,582
-725,010
| -53% | -$40.3M | 0.22% | 114 |
|
|
2020
Q1 | $49.9M | Hold |
1,377,592
| – | – | 0.23% | 121 |
|
|
2019
Q4 | $49.9M | Sell |
1,377,592
-178,641
| -11% | -$6.47M | 0.23% | 121 |
|
|
2019
Q3 | $42.4K | Sell |
1,556,233
-130,116
| -8% | -$3.54K | 0.19% | 142 |
|
|
2019
Q2 | $40.6K | Sell |
1,686,349
-315,846
| -16% | -$7.6K | 0.18% | 156 |
|
|
2019
Q1 | $52.9K | Sell |
2,002,195
-257,532
| -11% | -$6.81K | 0.24% | 115 |
|
|
2018
Q4 | $44.2K | Sell |
2,259,727
-191,974
| -8% | -$3.75K | 0.22% | 125 |
|
|
2018
Q3 | $48M | Sell |
2,451,701
-828,766
| -25% | -$16.2M | 0.19% | 163 |
|
|
2018
Q2 | $54.3M | Sell |
3,280,467
-358,706
| -10% | -$5.94M | 0.24% | 111 |
|
|
2018
Q1 | $53.1M | Hold |
3,639,173
| – | – | 0.22% | 124 |
|
|
2017
Q4 | $53.1M | Sell |
3,639,173
-317,808
| -8% | -$4.64M | 0.22% | 124 |
|
|
2017
Q3 | $50.2M | Buy |
3,956,981
+2,763,561
| +232% | +$35M | 0.22% | 132 |
|
|
2017
Q2 | $17.6M | Hold |
1,193,420
| – | – | 0.08% | 310 |
|
|
2017
Q1 | $17.6M | Buy |
1,193,420
+52,882
| +5% | +$779K | 0.08% | 310 |
|
|
2016
Q4 | $18.5M | Sell |
1,140,538
-909,661
| -44% | -$14.7M | 0.1% | 301 |
|
|
2016
Q3 | $37.2M | Buy |
+2,050,199
| New | +$37.2M | 0.21% | 143 |
|
|
2015
Q3 | – | Sell |
-542,278
| Closed | -$18.8M | – | 2891 |
|
|
2015
Q2 | $18.8M | Sell |
542,278
-511,863
| -49% | -$17.8M | 0.14% | 249 |
|
|
2015
Q1 | $27.4M | Buy |
+1,054,141
| New | +$27.4M | 0.2% | 153 |
|
|
2014
Q3 | – | Sell |
-2,335
| Closed | -$36K | – | 2538 |
|
|
2014
Q2 | $36K | Buy |
+2,335
| New | +$36K | ﹤0.01% | 1728 |
|